Side Effects from Wegovy: Deciding Whether to Continue

Wegovy's most common side effects are gastrointestinal (nausea, loose stools, constipation, indigestion) and typically peak around dose increases before settling.
In January 2026, the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as a known but infrequent serious risk with GLP-1 medicines.
Some side effects are a reason to stop immediately and call 111 or 999; others are manageable with small lifestyle changes and time.
You can report any suspected side effect from a prescription medicine directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Most people starting Wegovy experience some side effects, particularly in the first weeks of treatment. Semaglutide acts on GLP-1 receptors in the gut and brain, and that action brings real physiological change — which the body notices. For most, the effects are manageable and ease with time. For some, they're a signal to pause and speak to a prescriber. Knowing the difference matters. These are prescription-only medicines; a clinician assesses your suitability and talks through what to expect before you begin.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to read your side effects — and what to do with that information

The side effects most people on Wegovy actually experience

Nausea tops the list, and most people meet it early. It often arrives within hours of the first injection, fades over a few days, and returns briefly after each dose step up. Vomiting, loose stools, constipation and indigestion all feature in the same GI cluster. Burping and acid reflux are less discussed but genuinely common. Fatigue and headache appear too, usually in the first week at a new dose.

The pattern matters here. Side effects tend to spike at transitions (the move from 0.5mg to 1.0mg, or from 1.7mg to 2.4mg) not at a stable dose. If your symptoms are worst in the days after a new pen and then quiet down, that trajectory is expected. If you want to understand what a single side effect from Wegovy might look like in practice, that guide walks through individual reactions and what typically sits behind them. The NHS patient-level guide to semaglutide covers the full list and is worth reading alongside your Patient Information Leaflet.

Practical things that genuinely help: smaller, lower-fat meals, eating slowly, staying hydrated. If nausea is bad in the morning, some people find injecting in the evening helps, worth raising with your prescriber rather than making the call alone. Our frequently asked questions cover several of the adjustments patients ask about most.

When Wegovy side effects become something to act on quickly

The decision the page title refers to is this one: when does a side effect cross from uncomfortable to urgent? Three scenarios need prompt attention.

First, severe stomach pain that spreads to your back, with or without vomiting and lasting more than a few hours, this is the presentation profile the MHRA flagged in its January 2026 Drug Safety Update for GLP-1 medicines as a potential sign of acute pancreatitis. It is uncommon, but it can be serious. Stop the injection and get medical help that day. Call 111 if you're unsure, 999 if the pain is severe.

Second, symptoms of a serious allergic reaction: swelling of the face, throat or tongue, difficulty breathing, a rapid or pounding heartbeat alongside a rash. This needs emergency care immediately.

Third, signs of significant dehydration from prolonged vomiting or diarrhoea, dizziness, very dark urine, feeling faint. Severe fluid loss can affect kidney function. This warrants a call to 111 or your GP the same day, not waiting to see if it improves.

Gallbladder problems (pain in the upper right abdomen, sometimes with fever or jaundice) and sudden changes to vision in people with diabetes are also reasons to contact a doctor without delay. A more detailed breakdown of the more serious end of the spectrum is covered in our guide to severe Wegovy side effects.

The side effects some people don't get, and what that means

It's worth naming directly: a proportion of people start Wegovy and have very little trouble at all. Nausea stays mild. The GI disruption stays in the background. If that's you, it doesn't mean the treatment isn't working, and it doesn't mean you've done something wrong. Our guide for people who notice few or no side effects addresses that question specifically.

What the absence of side effects does not tell you is whether you're in the right treatment for your situation. That's a clinical question, and it's exactly the kind of thing a prescriber reviews as part of ongoing care rather than leaving you to interpret alone.

Reporting side effects and getting the right support

The MHRA's Yellow Card scheme lets patients and carers report suspected side effects directly. You don't need a healthcare professional to do it. Reporting helps build the evidence base for medicines that, for Wegovy, is still accumulating, both treatments carry a Black Triangle (▼) status, indicating they're subject to additional MHRA monitoring while in wider use.

If you started treatment elsewhere and have questions about what you're experiencing, the right route is back to your prescriber, not to dose-adjust independently or stop abruptly without advice. For a fuller picture of the side effects that can come with taking Wegovy, including how they tend to change over time and what influences their severity, that guide is a useful reference alongside any conversation with your prescriber. At nume, our clinical team provides aftercare seven days a week, so if a side effect question comes up on a Friday evening or over a bank holiday, you're not waiting until the following Monday to reach someone. That's not a small thing when nausea is making the week difficult.

Wegovy is a prescription medicine; questions about suitability, side effects and whether to continue are part of the clinical relationship that comes with a legitimate prescription. If you're thinking about starting treatment, our free consultation is the place to begin, prescribers discuss what to expect as part of every assessment. For a broader look at the treatment itself, the Wegovy overview covers how it works, who it's licensed for and how the UK rollout is progressing. You may also find it helpful to read about side effects from semaglutide more generally, since the active ingredient is the same and the wider evidence base offers useful context.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions